We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Novel Technology Diagnoses Stroke Quickly

By LabMedica International staff writers
Posted on 08 Dec 2015
A new approach to identifying biomarkers in blood has proven successful in helping diagnose stroke, and the technology could be expanded to diagnose such conditions as concussion, some forms of dementia, and some types of cancer and heart disease.

There is pressing need for quick and objective diagnostic technologies for both time sensitive and difficult to diagnose pathologies. More...
Much attention has therefore focused on the identification of disease-specific peripheral biomarkers, and use of new technologies to improve antibody-based detection capabilities.

Scientists at Cornell University (Ithaca, NY, USA) and their colleagues used a biomimicry-based approach to demonstrate a new diagnostic platform, based on enzymes tethered to nanoparticles (NPs). As proof of principle, they used oriented immobilization of pyruvate kinase (PK) and luciferase (Luc) on silica NPs to achieve rapid and sensitive detection of neuron-specific enolase (NSE), a clinically relevant biomarker for multiple diseases ranging from acute brain injuries to lung cancer.

They performed in vitro, animal model, and human subject studies. They used tethered enzyme assay for detection of NSE in samples from 20 geriatric human patients. Freshly collected plasma was diluted with water and added to individual wells of a 96-well plate preloaded with lyophilized Tethered Enzyme Technology (TET) reagent mixtures for negative, test and positive control wells in triplicates. The readout luminescence signal was integrated for 0.4 seconds, and read continuously for 25 minutes using a Safire plate reader (TECAN; Männedorf, Switzerland). For calculation of NSE levels, the linear regression slope for the initial activity was calculated per each well.

The scientists found that their data correlated very well with the current gold standard for biomarker detection, enzyme-linked immunosorbent assay (ELISA) with a major difference being that they achieved detection in 10 minutes as opposed to the several hours required for traditional ELISA. Alexander J. Travis, VMD, PhD an Associate Professor of Reproductive Biology, and lead author of the study said, “This system could be tailored to detect multiple biomarkers. That's the strength of the technique. You could assemble a microfluidic card based on this technology that could detect ten biomarkers in different wells, and the readout would be the same for each one: light. Using the same detection system for multiple different biomarkers would make for a simple system in a relatively small package.” The study was published on November 25, 2015, in the journal Public Library of Science ONE.

Cornell University 
TECAN 

Related Links:

Gold Member
Veterinary Hematology Analyzer
Exigo H400
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Specimen Radiography System
TrueView 200 Pro
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.